ES2261383T5 - Un metodo para mantener o mejorar la sintesis de mucinas. - Google Patents
Un metodo para mantener o mejorar la sintesis de mucinas. Download PDFInfo
- Publication number
- ES2261383T5 ES2261383T5 ES01911559T ES01911559T ES2261383T5 ES 2261383 T5 ES2261383 T5 ES 2261383T5 ES 01911559 T ES01911559 T ES 01911559T ES 01911559 T ES01911559 T ES 01911559T ES 2261383 T5 ES2261383 T5 ES 2261383T5
- Authority
- ES
- Spain
- Prior art keywords
- threonine
- protein
- source
- patient
- synthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000015572 biosynthetic process Effects 0.000 title claims description 42
- 238000003786 synthesis reaction Methods 0.000 title claims description 42
- 238000000034 method Methods 0.000 title description 5
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims abstract description 100
- 239000004473 Threonine Substances 0.000 claims abstract description 100
- 239000000203 mixture Substances 0.000 claims abstract description 89
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 76
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 76
- 235000016709 nutrition Nutrition 0.000 claims abstract description 53
- 150000001413 amino acids Chemical class 0.000 claims abstract description 30
- 238000002360 preparation method Methods 0.000 claims abstract description 28
- 201000010099 disease Diseases 0.000 claims abstract description 24
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 24
- 230000004075 alteration Effects 0.000 claims abstract description 11
- 235000018102 proteins Nutrition 0.000 claims description 75
- 108010046377 Whey Proteins Proteins 0.000 claims description 13
- 102000007544 Whey Proteins Human genes 0.000 claims description 13
- 150000002632 lipids Chemical class 0.000 claims description 12
- 238000012423 maintenance Methods 0.000 claims description 11
- 239000005862 Whey Substances 0.000 claims description 10
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 235000014633 carbohydrates Nutrition 0.000 claims description 6
- 229940057917 medium chain triglycerides Drugs 0.000 claims description 6
- 150000003626 triacylglycerols Chemical class 0.000 claims description 6
- 235000021119 whey protein Nutrition 0.000 claims description 3
- 235000005911 diet Nutrition 0.000 description 43
- 230000037213 diet Effects 0.000 description 41
- 102000015728 Mucins Human genes 0.000 description 38
- 108010063954 Mucins Proteins 0.000 description 38
- 102000001621 Mucoproteins Human genes 0.000 description 26
- 108010093825 Mucoproteins Proteins 0.000 description 26
- 241000700159 Rattus Species 0.000 description 23
- 235000008935 nutritious Nutrition 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 14
- 230000000050 nutritive effect Effects 0.000 description 13
- 229940051875 mucins Drugs 0.000 description 11
- 206010061218 Inflammation Diseases 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 230000004054 inflammatory process Effects 0.000 description 10
- 230000008901 benefit Effects 0.000 description 9
- 210000003097 mucus Anatomy 0.000 description 9
- 235000013305 food Nutrition 0.000 description 8
- 230000000968 intestinal effect Effects 0.000 description 8
- 230000036961 partial effect Effects 0.000 description 8
- 230000006872 improvement Effects 0.000 description 7
- 235000020940 control diet Nutrition 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 208000011231 Crohn disease Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 239000013589 supplement Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 4
- 210000001630 jejunum Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000009469 supplementation Effects 0.000 description 4
- 239000004474 valine Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000037894 acute intestinal inflammation Diseases 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010009900 Colitis ulcerative Diseases 0.000 description 2
- 201000003883 Cystic fibrosis Diseases 0.000 description 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 2
- 206010022678 Intestinal infections Diseases 0.000 description 2
- 108010044422 Peptamen Proteins 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000009331 sowing Methods 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010070545 Bacterial translocation Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000557626 Corvus corax Species 0.000 description 1
- 101100094857 Danio rerio slc22a6 gene Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010017865 Gastritis erosive Diseases 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229930182473 O-glycoside Natural products 0.000 description 1
- 150000008444 O-glycosides Chemical class 0.000 description 1
- 101150010952 OAT gene Proteins 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 210000001815 ascending colon Anatomy 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000007375 bacterial translocation Effects 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- -1 bile Proteins 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 235000015496 breakfast cereal Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 210000001731 descending colon Anatomy 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 208000008384 ileus Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 235000020888 liquid diet Nutrition 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000009854 mucosal lesion Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 235000003784 poor nutrition Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 210000001599 sigmoid colon Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Obesity (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US774814 | 1985-09-13 | ||
| US49890500A | 2000-02-04 | 2000-02-04 | |
| US498905 | 2000-02-04 | ||
| US09/774,814 US6833350B2 (en) | 2000-02-04 | 2001-01-30 | Method for maintaining or improving the synthesis of mucins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2261383T3 ES2261383T3 (es) | 2010-06-14 |
| ES2261383T5 true ES2261383T5 (es) | 2010-06-18 |
Family
ID=27052980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES01911559T Expired - Lifetime ES2261383T5 (es) | 2000-02-04 | 2001-01-31 | Un metodo para mantener o mejorar la sintesis de mucinas. |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1255452B2 (hu) |
| JP (1) | JP2003533436A (hu) |
| CN (1) | CN1434681B (hu) |
| AT (1) | ATE323422T1 (hu) |
| AU (1) | AU784137B2 (hu) |
| BG (1) | BG106967A (hu) |
| BR (1) | BRPI0108096B1 (hu) |
| CA (1) | CA2399063C (hu) |
| CZ (1) | CZ20022978A3 (hu) |
| DE (1) | DE60118888T3 (hu) |
| DZ (1) | DZ3298A1 (hu) |
| ES (1) | ES2261383T5 (hu) |
| HR (1) | HRP20020647A2 (hu) |
| HU (1) | HUP0204439A3 (hu) |
| IL (1) | IL150977A (hu) |
| MA (1) | MA25656A1 (hu) |
| MX (1) | MXPA02007491A (hu) |
| NO (1) | NO20023640L (hu) |
| NZ (1) | NZ520605A (hu) |
| PL (1) | PL357078A1 (hu) |
| SK (1) | SK11212002A3 (hu) |
| WO (1) | WO2001056405A2 (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2391558T3 (es) | 2003-06-23 | 2012-11-27 | Nestec S.A. | Suplemento de aminoácidos para un ecosistema microbiótico sano |
| WO2007004613A1 (ja) * | 2005-07-01 | 2007-01-11 | Ajinomoto Co., Inc. | 炎症性腸疾患治療薬及びＴＮＦ－α産生抑制剤 |
| CA2631220A1 (en) * | 2006-01-09 | 2007-07-19 | Nestec S.A. | Treatment of stressed patients |
| WO2012133198A1 (ja) * | 2011-03-25 | 2012-10-04 | イーエヌ大塚製薬株式会社 | 炎症性疾患用栄養組成物 |
| ES2657744T3 (es) | 2011-07-22 | 2018-03-06 | Abbott Laboratories | Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal |
| EP3167895A1 (en) * | 2015-11-10 | 2017-05-17 | University College Dublin | A dietary supplement comprising beta-glucan and casein hydrolysate for improving health and growth performance in a mammal |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2459620B1 (fr) * | 1979-06-26 | 1983-08-05 | Agronomique Inst Nat Rech | Hydrolisat enzymatique total de proteines de lactoserum, obtention et application |
| US5162373A (en) * | 1986-01-17 | 1992-11-10 | Board Of Regents, The University Of Texas System | Methods and improved formulations for the determination and treatment of malignant disease in patients |
| JP2631470B2 (ja) * | 1987-05-15 | 1997-07-16 | 雪印乳業株式会社 | 感染防御剤 |
| CA1338682C (en) * | 1988-12-23 | 1996-10-29 | Gustavo Bounous | Biologically active undenatured whey protein concentrate as food supplement |
| JP2805490B2 (ja) * | 1989-02-07 | 1998-09-30 | 雪印乳業株式会社 | 細菌毒素中和剤 |
| JP3007694B2 (ja) * | 1990-12-14 | 2000-02-07 | 雪印乳業株式会社 | 胃潰瘍予防または治療のための医薬及び飲食品 |
| AU679020B2 (en) * | 1992-12-23 | 1997-06-19 | Abbott Laboratories | Medical foods for the nutritional support of infant/toddler metabolic diseases |
| NZ248605A (en) * | 1993-05-28 | 1994-12-22 | Abbott Lab | Enteral nutritional product comprising protein and fat |
| FR2711529B1 (fr) * | 1993-10-28 | 1996-07-05 | Clintec Nutrition Cy | Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme. |
| JPH07267855A (ja) * | 1994-03-30 | 1995-10-17 | Taiho Yakuhin Kogyo Kk | グルタミン産生剤 |
| US5952314A (en) * | 1994-04-01 | 1999-09-14 | Demichele; Stephen Joseph | Nutritional product for a person having ulcerative colitis |
| US5728678A (en) * | 1995-06-06 | 1998-03-17 | Nestec Ltd. | Method and composition for providing nutrition to a renal failure patient |
| US5670157A (en) * | 1995-12-11 | 1997-09-23 | Nestec Ltd. | Method for reducing and controlling immunoglobulin concentrations |
| US5922766A (en) * | 1997-07-02 | 1999-07-13 | Acosta; Phyllis J. B. | Palatable elemental medical food |
| CA2300076A1 (en) * | 1997-09-16 | 1999-03-25 | Societe Des Produits Nestle S.A. | Organ specific nutrition |
| CA2331921A1 (en) * | 1998-06-24 | 1999-12-29 | Boyce Thompson Institute For Plant Research, Inc. | A novel invertebrate intestinal mucin cdna and related products and methods |
| EP1034704A1 (en) * | 1999-03-12 | 2000-09-13 | Societe Des Produits Nestle S.A. | Nutritional composition intended for specific gastro-intestinal maturation in premature mammals |
| NZ518319A (en) * | 1999-10-22 | 2004-04-30 | Univ Nebraska | Nucleic acid molecules encoding serum amyloid A isoforms from mammalian colostrum used to treat and prevent enteric infections |
-
2001
- 2001-01-31 IL IL15097701A patent/IL150977A/xx not_active IP Right Cessation
- 2001-01-31 ES ES01911559T patent/ES2261383T5/es not_active Expired - Lifetime
- 2001-01-31 EP EP01911559A patent/EP1255452B2/en not_active Expired - Lifetime
- 2001-01-31 JP JP2001556111A patent/JP2003533436A/ja active Pending
- 2001-01-31 PL PL01357078A patent/PL357078A1/xx not_active Application Discontinuation
- 2001-01-31 CN CN018074375A patent/CN1434681B/zh not_active Expired - Lifetime
- 2001-01-31 DE DE60118888T patent/DE60118888T3/de not_active Expired - Lifetime
- 2001-01-31 CA CA2399063A patent/CA2399063C/en not_active Expired - Lifetime
- 2001-01-31 NZ NZ520605A patent/NZ520605A/en unknown
- 2001-01-31 WO PCT/EP2001/001013 patent/WO2001056405A2/en active IP Right Grant
- 2001-01-31 MX MXPA02007491A patent/MXPA02007491A/es unknown
- 2001-01-31 AU AU40564/01A patent/AU784137B2/en not_active Ceased
- 2001-01-31 SK SK1121-2002A patent/SK11212002A3/sk unknown
- 2001-01-31 CZ CZ20022978A patent/CZ20022978A3/cs unknown
- 2001-01-31 BR BRPI0108096A patent/BRPI0108096B1/pt active IP Right Grant
- 2001-01-31 AT AT01911559T patent/ATE323422T1/de not_active IP Right Cessation
- 2001-01-31 HU HU0204439A patent/HUP0204439A3/hu unknown
- 2001-01-31 DZ DZ013298A patent/DZ3298A1/fr active
-
2002
- 2002-07-31 BG BG106967A patent/BG106967A/bg unknown
- 2002-07-31 HR HRP20020647 patent/HRP20020647A2/hr not_active Application Discontinuation
- 2002-07-31 NO NO20023640A patent/NO20023640L/no unknown
- 2002-08-30 MA MA26798A patent/MA25656A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL150977A0 (en) | 2003-02-12 |
| HRP20020647A2 (en) | 2004-12-31 |
| ES2261383T3 (es) | 2010-06-14 |
| PL357078A1 (en) | 2004-07-12 |
| CA2399063C (en) | 2014-01-28 |
| DE60118888T3 (de) | 2010-09-23 |
| HUP0204439A2 (hu) | 2003-04-28 |
| EP1255452B2 (en) | 2010-03-03 |
| SK11212002A3 (sk) | 2003-01-09 |
| NZ520605A (en) | 2004-06-25 |
| DZ3298A1 (fr) | 2001-08-09 |
| CA2399063A1 (en) | 2001-08-09 |
| JP2003533436A (ja) | 2003-11-11 |
| CN1434681A (zh) | 2003-08-06 |
| MXPA02007491A (es) | 2002-12-13 |
| EP1255452B1 (en) | 2006-04-19 |
| MA25656A1 (fr) | 2002-12-31 |
| AU4056401A (en) | 2001-08-14 |
| CN1434681B (zh) | 2010-12-08 |
| BG106967A (bg) | 2003-04-30 |
| IL150977A (en) | 2005-09-25 |
| ATE323422T1 (de) | 2006-05-15 |
| NO20023640L (no) | 2002-09-19 |
| NO20023640D0 (no) | 2002-07-31 |
| DE60118888T2 (de) | 2007-01-18 |
| BR0108096A (pt) | 2002-10-29 |
| WO2001056405A2 (en) | 2001-08-09 |
| DE60118888D1 (de) | 2006-05-24 |
| BRPI0108096B1 (pt) | 2017-05-09 |
| AU784137B2 (en) | 2006-02-09 |
| WO2001056405A3 (en) | 2002-01-24 |
| EP1255452A2 (en) | 2002-11-13 |
| CZ20022978A3 (cs) | 2003-02-12 |
| HUP0204439A3 (en) | 2004-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2278781T3 (es) | Compuesto nutritivo y metodo para mejorar la sedimentacion de proteinas. | |
| ES2288775T3 (es) | Producto nutricional enteral elemental que contiene proteina de soja hidrolizada y caseinato parcialmente hidrolizado. | |
| ES2215304T3 (es) | Alimentacion medica elemental de sabor agradable. | |
| ES2269514T3 (es) | Compuesto nutritivo para tratar afecciones inmunologicas. | |
| ES2449016T3 (es) | Composiciones prebióticas | |
| ES2221676T3 (es) | Suplemento nutricional para pacientes pediatricos. | |
| JP6285108B2 (ja) | 術前及び／又は術後環境におけるプロバイオティックス | |
| ES2289142T3 (es) | Composiciones nutricionales para el control del nivel de glucosa en sangre. | |
| ES2552525T3 (es) | Productos nutritivos que incluyen un sistema graso que incluye ácidos grasos libres | |
| JP2006503105A (ja) | ロイシンに富んだ栄養的組成物 | |
| ES2314485T3 (es) | Composiciones que comprenden acido pantotenico o derivados del mismo y su uso para estimular el apetito. | |
| ES2261383T5 (es) | Un metodo para mantener o mejorar la sintesis de mucinas. | |
| EP1972345A1 (en) | Food product for enteral or oral nutrition | |
| ES2586669T3 (es) | Batido de frutas con base láctea para estimular el crecimiento en niños | |
| EP0852913A1 (en) | Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract | |
| US20170368026A1 (en) | Promotion of healing of intestinal mucosa using proline, serine and threonine | |
| US20090137459A1 (en) | Food Product for Enteral or Oral Nutrition | |
| US6833350B2 (en) | Method for maintaining or improving the synthesis of mucins | |
| ES2899639T3 (es) | Betaína para la prevención de la obesidad | |
| ES2951327T3 (es) | Butirato dietético para el tratamiento o la prevención de un trastorno alérgico | |
| CN116548608B (zh) | 一种儿童全营养配方粉及其制备方法和应用 |